Abbott shares sag as global diagnostic, nutrition business sales declines drag on earnings
Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22, as the market digested weaknesses from its fourth-quarter and full-year earnings report. | Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22 as the market digested weaknesses from its fourth-quarter and full-year earnings report.
Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22, as the market digested weaknesses from its fourth-quarter and full-year earnings report. | Abbott Laboratories saw its shares down 10% at the end of trading Thursday, Jan. 22 as the market digested weaknesses from its fourth-quarter and full-year earnings report.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
